InsidersTradesSigma
Track the 대한약품 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 대한약품 has recorded 8 reports. Market capitalisation: €155.5bn. The latest transaction was reported on 30 June 2026 (Purchase). Among the most active insiders: 이윤우. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
대한약품 es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en la fabricación y distribución de productos farmacéuticos.